Marie‐Carmelle Elie

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 127 citations · Full text

Long Covid, Clinical Therapeutic, Covid-19 Pandemic +6

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

John H. Beigel, Pablo Tebas, Marie‐Carmelle Elie et al. · The Lancet Respiratory Medicine · 2017 · 117 citations · Full text

Vaccination, Immune Plasma, Immunology +7

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial

John H. Beigel, Evgenia Aga, Marie‐Carmelle Elie et al. · The Lancet Respiratory Medicine · 2019 · 109 citations · Full text

Vaccination, Clinical Trials, Vaccine Trial +6

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

John H. Beigel, Yajing Bao, Joy Beeler et al. · The Lancet Infectious Diseases · 2017 · 94 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5